MicrobeWorld App

appsquarebannerad200x200

Join MicrobeWorld

Subscribe via Email

subscribe

Microbes After Hours

MW-Site-Banner-200x200

Click for more "Microbes After Hours" videos

Featured Image

Featured Video

Crowdsourced Microbes Heading to Station

Supporters

ASM House 200X200

The FDA Fast Tracks a Vaccine to Fight Pneumonia in Older Adults

Image
U.S. health regulators approved the expansion of Pfizer Inc's blockbuster Prevnar vaccine for use in adults 50 and older to fight pneumonia, meningitis, and other diseases cause by pneumococcus bacteria.

Prevnar 13 is designed to fight 13 forms of a bacterium called Streptococcus pneumoniae, or pneumococcus. Pneumonia caused by the pneumococcal organism is one of the biggest causes of death in older people and its incidence begins to increase after age 50.

The vaccine, which had been approved for children in the United States, is already one of Pfizer's biggest brands and an expanded population of adults could generate more than $1.5 billion in annual sales.
 
 

Comments (0)

Collections (0)

 

American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
American Society For Microbiology © 2014   |   Privacy Policy   |   Terms of Use